了解天然生物活性成分对呼吸道炎症疾病的影响
Jincan Luo1,2,3, Jinhai Luo4, Zhonghao Fang1,2
1National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Phytotherapy research : PTR
|August 6, 2025
概括
自然化合物在治疗喘和COPD等呼吸道炎症疾病方面表现有前途. 这些生物活性成分,包括黄素和人参化物,准关键的分子通路,为新的功能性食品和药物开发提供了潜力.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 全球呼吸道炎症疾病的流行率不断上升.
- 这些疾病包括喘,COPD,COVID-19和肺癌.
- 这些疾病由于患病率高和预后不佳,造成了重大临床挑战.
研究的目的:
- 审查呼吸道炎症疾病的分子机制.
- 总结自然生物活性成分的治疗潜力.
- 探索用于功能性食品和药物开发的天然产品.
主要方法:
- 通过科学网,PubMed和谷歌学者进行全面的文献搜索.
- 关键词:生物活性成分,炎症性疾病,呼吸道.
- 专注于体外,体内和临床试验数据.
主要成果:
- 天然生物活性成分在炎症性呼吸道疾病上表现出治疗作用.
- 植物化学物质,如黄素,人参化物,沙夫兰和黑激素调节关键信号通路 (PI3K/Akt,NF-κB,NRF2/HO-1,MAPK).
- 这些化合物通过路径调节提供了潜在的干预措施.
结论:
- 天然生物活性成分在治疗呼吸道炎症疾病方面具有前景.
- 进一步的高质量研究对于确认临床疗效至关重要.
- 为开发天然产品作为功能性食品或药物道提供了洞察力.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583
Inflammatory Response
7.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Antiasthma Drugs: Leukotriene Modifiers
475
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
475
Asthma: Pathogenesis and Management
593
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
394
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
394


